泰格医药 港股通 空最新回购 (2026-06-25) 官网 ( 03347.hk) | 382.62 | 1.54 | 0.36% (0.35%) | 上市时间2020-08-07股价40.200港币涨跌幅-3.50%成交金额6,842.17万港币换手率0.19%总市值346.13亿港币H股市值49.50亿港币总股本8.61亿H股本1.23亿每手股数100 港股通持仓占H股比例41.22% (21.06亿港币2026-10-14) 累计做空占H股比例12.90% (7.08亿港币2026-10-09) 上市至今年化投资收益率-14.49% | |||
| 所属三级行业医药及生物科技合约服务 (恒生) | 市盈率 | 38.30 | 市净率 | 3.99 | 股息率 | 0.71% | 恒生:医疗保健业药品及生物科技医药及生物科技合约服务 |
| 所属指数指数纳入纳出 | |||||||
| 同股同权 | 查看历史折扣 | ||||||
| 备注 (4): | 双击编辑备注 |
泰格医药(03347) - 历史董事名单
| # | 姓名 | 职衔 | 职位 | 委任日期 | 辞任日期 |
|---|---|---|---|---|---|
| 1 | 聞增玉 | Executive Director | 2023-05-23 | -- | |
| 2 | 袁華剛 | Independent Non Executive Director | 2023-05-23 | -- | |
| 3 | 吳灝 | Executive Director | 2021-10-15 | -- | |
| 4 | 廖啟宇 | Independent Non Executive Director - A/F | 2020-04-01 | -- | |
| 5 | 楊波 | Independent Non Executive Director | 2020-04-01 | -- | |
| 6 | 鄭碧筠 | Independent Non Executive Director | 2017-06-01 | 2023-05-23 | |
| 7 | 曹曉春 | Executive Director | 2010-09-01 | -- | |
| 8 | 葉小平 | Executive Director | Chairman | 2010-09-01 | -- |
| 9 | YIN Zhuan | Executive Director | 2010-09-01 | 2023-05-23 |